These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 18759005
1. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells. Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G. Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005 [Abstract] [Full Text] [Related]
2. Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells. Hromadnikova I, Li S, Kotlabova K, Dickinson AM. PLoS One; 2016; 11(3):e0151535. PubMed ID: 26982331 [Abstract] [Full Text] [Related]
3. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors. Hromadnikova I, Pirkova P, Sedlackova L. Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104 [Abstract] [Full Text] [Related]
4. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells. Moser C, Schmidbauer C, Gürtler U, Gross C, Gehrmann M, Thonigs G, Pfister K, Multhoff G. Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481 [Abstract] [Full Text] [Related]
5. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation. Gross C, Holler E, Stangl S, Dickinson A, Pockley AG, Asea AA, Mallappa N, Multhoff G. Leuk Res; 2008 Apr; 32(4):527-34. PubMed ID: 17543383 [Abstract] [Full Text] [Related]
7. The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells. Wang F, Bashiri Dezfouli A, Multhoff G. Mol Immunol; 2024 Oct; 174():1-10. PubMed ID: 39126837 [Abstract] [Full Text] [Related]
11. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report. Milani V, Stangl S, Issels R, Gehrmann M, Wagner B, Hube K, Mayr D, Hiddemann W, Molls M, Multhoff G. J Transl Med; 2009 Jun 23; 7():50. PubMed ID: 19549307 [Abstract] [Full Text] [Related]
12. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Ulbrecht M, Hofmeister V, Yüksekdag G, Ellwart JW, Hengel H, Momburg F, Martinozzi S, Reboul M, Pla M, Weiss EH. Hum Immunol; 2003 Feb 23; 64(2):231-7. PubMed ID: 12559625 [Abstract] [Full Text] [Related]
13. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. Proc Natl Acad Sci U S A; 1997 May 13; 94(10):5249-54. PubMed ID: 9144223 [Abstract] [Full Text] [Related]
16. Human T cell receptor-mediated recognition of HLA-E. García P, Llano M, de Heredia AB, Willberg CB, Caparrós E, Aparicio P, Braud VM, López-Botet M. Eur J Immunol; 2002 Apr 13; 32(4):936-44. PubMed ID: 11920559 [Abstract] [Full Text] [Related]